ENTITY
Divi's Laboratories

Divi's Laboratories (DIVI IN)

106
Analysis
Health Care • India
Divi's Laboratories Ltd. manufactures pharmaceutical products which include generic drugs and their intermediates. The Company also undertakes contract research activities for other pharmaceutical companies.
more
•28 Oct 2020 13:51

Sensex Index Rebalance Preview: Take Profit on Strong Outperformance

With the review period for the Sensex almost complete, we still see DRRD as a high probability inclusion and ONGC as a deletion. With DRRD...

Logo
475 Views
Share
bullish•Cross Asset Strategy
•21 Oct 2020 03:04

India:  Confidence Returns Among EM Active Managers

Global EM managers strengthen India exposure during the recent market turbulence.  Ownership increases across Energy and Consumer Discretionary,...

Logo
342 Views
Share
•06 Sep 2020 14:25

Sensex Index Rebalance Preview: Early Look Sees One Change, Maybe Two

The S&P BSE Sensex is the flagship index of the Bombay Stock Exchange (BSE). The index has 30 stocks and is a free float weighted market cap...

Logo
808 Views
Share
•21 Aug 2020 05:59

NIFTY50 Index Rebalance - SBI Life Could Outperform on Index Inclusion

Last evening, the Index Maintenance Sub-Committee (IMSC) of NSE Indices announced the results of the September index review for the NIFTY Index...

Logo
585 Views
Share
bearish•HDFC Life Insurance
•29 Jul 2020 07:19

NIFTY50 Index Rebalance - HDFC Life at All Time High On Inclusion, Time to Switch

On 2 July, the Index Maintenance Sub-Committee (IMSC) of NSE Indices Limited made an ad-hoc change to the NIFTY Index (NIFTY...

Logo
647 Views
Share
x